Unlock Faster Diagnoses: How AI Chest X-rays Transform Indian Healthcare

When Prashant Warier co-founded Qure.ai nearly a decade ago, artificial intelligence in healthcare was largely experimental. Today, their AI algorithms help interpret millions of medical images annually. Crucially, in some countries, these algorithms are even replacing the need for human readers in critical cases. Indeed, the advent of AI chest X-ray technology specifically addresses a significant gap in healthcare, particularly prevalent in India.

Bridging the Radiologist Gap with AI

Chest X-rays, the most common and oldest form of medical imaging, were often not being read by radiologists in India and other parts of the world. Instead, general practitioners or technicians frequently handled interpretation. Consequently, patients sometimes received no report at all. Qure.ai aimed to automate this critical process, training AI models on a vast volume of de-identified clinical images sourced through hospital partnerships. The company now collaborates with over 100 healthcare institutions globally, having built a dataset exceeding 1.5 billion images.

For instance, their flagship product, qXR, is a powerful tool designed to detect abnormalities in chest X-rays, including signs of tuberculosis, in under 30 seconds. This tool is currently deployed in screening programs across several countries, like the Philippines, where mobile vans equipped with X-ray machines use qXR to produce real-time readings. Previously, such scans could take weeks for interpretation. Furthermore, Qure.ai’s qXR significantly increases TB detection rates and proves cost-effective in high-burden regions of India. [15] One study in Nagpur, India, demonstrated a 15.8% increase in TB yield attributable to AI alone. [5, 13]

Key Milestones and Regulatory Journey

In 2021, the World Health Organization formally endorsed Qure.ai’s solution as an autonomous tool for TB detection, requiring no human review. [7] This marked a key inflection point for the company. This is also now the most scaled use-case of autonomous AI in healthcare, with the system analyzing between 5 to 10 million X-rays annually. This widespread adoption underscores the technology’s effectiveness and reliability.

Qure.ai’s path to adoption has involved considerable regulatory rigor. AI used in clinical pathways is considered a medical device, necessitating stringent regulatory approval for every deployment. For example, the company spent three years obtaining its first FDA clearance in the U.S. and now holds 18 regulatory approvals, including CE certification in Europe. Each submission typically requires data from the local population and independent comparison against certified radiologists. This highlights the importance of specialized knowledge in medical imaging interpretation, which can be further developed through courses like the Certification Course In Clinical Imaging.

AI: An Indispensable Clinical Assist

Prashant Warier emphasizes that AI’s role is not to replace physicians but to support them. While automation can handle high-volume, routine imaging, tasks like diagnosis confirmation, treatment planning, and patient communication remain with clinicians. He states, “AI will be there throughout the patient journey, but it will be an assist.” Therefore, clinicians can focus on complex cases and patient-centric care, enhancing overall efficiency. [4] This collaborative approach between AI and clinicians is crucial across various medical specialities, including fields like emergency medicine.

The Future of AI Chest X-ray in India

Looking ahead, Warier anticipates AI taking over more foundational tasks in radiology, such as flagging abnormalities, creating template reports, and improving scan-to-diagnosis times. As India’s digital health infrastructure evolves, particularly with the introduction of personal health IDs and medical data interoperability, the accuracy and value of AI in healthcare will continue to rise. AI is significantly enhancing image processing through noise reduction and improved diagnostic precision. [6] Experts foresee greater integration of AI in radiology workflows, reducing manual workloads and expanding teleradiology services to rural and underserved areas. [3, 11] For professionals looking to deepen their expertise in this evolving field, understanding the nuances of radiology is essential.

Qure.ai is currently active in 90 countries, with a growing presence in low- and middle-income regions where radiology expertise is scarce. The company’s approach, Warier affirms, remains grounded in utility: “We started by solving a problem nobody else was looking at.”

References

1. No Radiologist, No Problem: Qure.ai’s AI Takes the X-Ray Lead – ETHealthworld. Published On Jul 31, 2025.
2. Implementing a chest X-ray artificial intelligence tool to enhance tuberculosis screening in India: Lessons learned – PubMed Central. Published December 7, 2023.
3. AI-enabled imaging shows immense promise in India – Express Healthcare. Published August 15, 2024.